Pharmaceuticals Ultrasector is trading at 19.16 as of the 20th of July 2025; that is 1.64 percent down since the beginning of the trading day. The fund's open price was 19.48. Pharmaceuticals Ultrasector has about a 23 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 21st of April 2025 and ending today, the 20th of July 2025. Click here to learn more.
The fund invests in financial instruments that the fund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the pharmaceuticals segment of the SP Total Market Index, which comprises the following sub-industry pharmaceuticals. More on Pharmaceuticals Ultrasector Profund
Pharmaceuticals Ultrasector Profund [PHPSX] is traded in USA and was established 20th of July 2025. Pharmaceuticals Ultrasector is listed under ProFunds category by Fama And French industry classification. The fund is listed under Trading--Leveraged Equity category and is part of ProFunds family. This fund at this time has accumulated 10.07 M in assets with minimum initial investment of 15 K. Pharmaceuticals Ultrasector is currently producing year-to-date (YTD) return of 1.85%, while the total return for the last 3 years was -6.99%.
Check Pharmaceuticals Ultrasector Probability Of Bankruptcy
Instrument Allocation
Top Pharmaceuticals Ultrasector Profund Mutual Fund Constituents
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.